The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe | NCT01389232 | Trialant
CompletedInterventionalNot ApplicableUpdated Jun 21, 2021
The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe
ClinicalTrials.gov ID
NCT01389232
Lead Sponsor
Sofregen Medical, Inc.INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
104Actual
Last Update Posted
Jun 21, 2021Actual
Start Date
Jun 2011
Primary Completion Date
Aug 2013Actual
Completion Date
Feb 2015Actual
Brief Summary
This is a post-market study of the use of SeriScaffold® for soft tissue support and repair in breast reconstruction surgery.
Soft Tissue Support and Repair
SeriScaffold® Surgical Scaffold
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Be female, greater or equal to 18 years of age
Be willing to undergo immediate breast reconstruction with sub-pectoralis muscle placement of a breast implant
Be willing to undergo mastectomy with healthy, well vascularized skin flaps anticipated by the surgeon
Be in good health other than breast pathology and be suited to general anesthesia and planned treatments
Exclusion Criteria:
Have undergone breast radiation treatment and/or is preoperatively evaluated to require radiation treatment to the breast area during the course of the study
Have a known allergy to silk
Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability
Have undergone previous breast surgery with the exception of mastectomy, breast biopsy, cyst removal, lumpectomy, mastopexy, reduction and/or augmentation
Have had a prior soft tissue support device implanted in the breast
Have a condition or be in a situation that, in the Investigator's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study